[1]
N. Varkhede and L. Forrest, “Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model”, J Pharm Pharm Sci, vol. 21, no. 1s, p. 130s-148s, Jul. 2018.